About IMNM Dividend Returns
Immunome, Inc. (IMNM) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.
How We Calculate Total Return
Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.
Frequently Asked Questions
Q1What is the total return of IMNM over the past year?
Immunome, Inc. (IMNM) delivered a return of 132.55% over the past year. Since IMNM does not currently pay dividends, the total return equals the price-only return.
Q2How much would $10,000 invested in IMNM be worth today?
A $10,000 investment in Immunome, Inc. one year ago would be worth $23,255 today, representing a gain of $13,255.
Q3Does IMNM pay dividends?
Immunome, Inc. (IMNM) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For IMNM, the total return equals the price-only return.
Q4Did IMNM beat the S&P 500?
Yes, Immunome, Inc. (IMNM) outperformed the S&P 500 by 117.10 percentage points over the past year. IMNM delivered a total return of 132.55%, compared to the S&P 500's 15.45%. This 117.10pp alpha means investors in IMNM earned more than a passive S&P 500 index fund.
Q5What is IMNM's worst drawdown?
Immunome, Inc. (IMNM) experienced a maximum drawdown of -40.85% over the past year, declining from its peak on 2025-02-28 to its trough on 2025-04-08. The stock recovered to its prior peak by 2025-06-10. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.
Q6What is IMNM's long-term total return over 10, 20, or 30 years?
Immunome, Inc. (IMNM) has delivered strong long-term returns with dividends reinvested. Over 10 years, the total return is 62.5% (5.0% CAGR) — $10,000 would have grown to $16,253. Over 20 years: 62.5% total return (2.5% CAGR) — $10,000 → $16,253. Over 30 years: 62.5% total return (1.6% CAGR) — $10,000 → $16,253. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.
Q7What was IMNM's best and worst year?
Immunome, Inc.'s best calendar year was 2023 with a total return of 228.2%. Its worst year was 2022 with a total return of -84.2%. This range shows the volatility investors should expect — the difference between the best and worst year is 312.4 percentage points.
Find the Best Dividend Stocks
Screen for dividend stocks with the highest total returns (including DRIP).